Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity
Obesity, Morbid
About this trial
This is an interventional treatment trial for Obesity, Morbid focused on measuring procedure: sleeve gastrectomy, bariatric surgery, procedure: single anastomosis sleeve ileal bypass
Eligibility Criteria
Inclusion Criteria: Morbid obesity at referral for bariatric surgery (i.e. a body-mass index [BMI] of ≥35 kg/m2 with obesity-related comorbid conditions or ≥40 kg/m2 with or without such comorbidities). Age 20-60 years. Previous failed attempts of weight loss. Norwegian speaking patients. Exclusion Criteria: BMI ≥55 kg/m2. A history of major abdominal or bariatric surgery (excluding appendectomy, cholecystectomy, and sectio). Established disabling cardiopulmonary disease, ongoing treatment for cancer, long-term steroid use, and conditions believed to be associated with poor adherence after surgery. Previous or current gastroesophageal reflux symptoms with daily use of antireflux medication. Patients are also excluded if preoperative manometry identifies a hiatal hernia (≥4cm in axial length) or if preoperative upper endoscopy identifies esophagitis grade C or D (LA classification), peptic stricture, Barrett's esophagus, or esophageal carcinoma. Achalasia Pregnancy.
Sites / Locations
- The Morbid Obesity Center, Vestfold Hospital Trust
- Oslo University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Single anastomosis sleeve ileal bypass
Sleeve gastrectomy
A Single anastomosis sleeve ileal bypass procedure is performed.
A sleeve gastrectomy procedure is performed.